- Home
- NWBI vs CNTA Comparison
NWBI vs CNTA Comparison
Compare NWBI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWBI
- CNTA
- Stock Information
- Founded
- NWBI 1896
- CNTA 2020
- Country
- NWBI United States
- CNTA United Kingdom
- Employees
- NWBI N/A
- CNTA N/A
- Industry
- NWBI Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- NWBI Finance
- CNTA Health Care
- Exchange
- NWBI Nasdaq
- CNTA Nasdaq
- Market Cap
- NWBI 1.9B
- CNTA 2.2B
- IPO Year
- NWBI N/A
- CNTA 2021
- Fundamental
- Price
- NWBI $14.72
- CNTA $16.00
- Analyst Decision
- NWBI Hold
- CNTA Strong Buy
- Analyst Count
- NWBI 3
- CNTA 7
- Target Price
- NWBI $11.67
- CNTA $23.71
- AVG Volume (30 Days)
- NWBI 723.3K
- CNTA 463.7K
- Earning Date
- NWBI 10-29-2024
- CNTA 11-12-2024
- Dividend Yield
- NWBI 5.43%
- CNTA N/A
- EPS Growth
- NWBI N/A
- CNTA N/A
- EPS
- NWBI 0.76
- CNTA N/A
- Revenue
- NWBI $487,913,000.00
- CNTA $6,853,000.00
- Revenue This Year
- NWBI N/A
- CNTA N/A
- Revenue Next Year
- NWBI $5.44
- CNTA N/A
- P/E Ratio
- NWBI $19.39
- CNTA N/A
- Revenue Growth
- NWBI N/A
- CNTA N/A
- 52 Week Low
- NWBI $10.45
- CNTA $5.58
- 52 Week High
- NWBI $15.36
- CNTA $18.74
- Technical
- Relative Strength Index (RSI)
- NWBI 62.16
- CNTA 49.07
- Support Level
- NWBI $14.68
- CNTA $15.15
- Resistance Level
- NWBI $15.17
- CNTA $18.74
- Average True Range (ATR)
- NWBI 0.38
- CNTA 0.88
- MACD
- NWBI 0.10
- CNTA 0.10
- Stochastic Oscillator
- NWBI 71.81
- CNTA 35.68
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and banking business solutions, investment management, trust services and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.